The Opioid Epidemic: A Review of the Contributing Factors, Negative Consequences, and Best Practices.

drug addiction opioid-related death opioids use prescription drug monitoring program substance abuse

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2023
Historique:
accepted: 10 07 2023
medline: 11 8 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: epublish

Résumé

The opioid epidemic is a significant public health crisis that has caused extensive harm and devastation in the United States. This literature review aimed to identify the contributing factors and negative consequences of the epidemic, as well as best practices for healthcare providers in managing the epidemic. Overprescribing opiates and opioids, lack of education and opportunity, and being unmarried or divorced were some of the identified contributing factors to dependence on opioids. The epidemic's negative consequences are substantial, leading to increased access to opioids for vulnerable populations, which consequently cause accidental death among men and the degradation of rural community health services. As part of the literature review, we also analyzed the best practices for healthcare providers, including implementing prescription drug monitoring programs (PDMPs). However, we found that while PDMPs resulted in a decrease in opioid overprescription and an increase in provider confidence when prescribing medication, the evidence for their effectiveness in improving rural community health services or reducing opioid overdoses and opioid-related deaths was inconclusive. Our review highlights that the greatest challenge to overcome is a lack of legal mandates and proper education for healthcare providers on best practices for addressing the epidemic. To regulate and control opioids effectively, tracking and standardizing prescription models by federal agencies and medical institutions is necessary but not enough. Legal action is vital for the successful containment of the opioid crisis.

Identifiants

pubmed: 37565101
doi: 10.7759/cureus.41621
pmc: PMC10410480
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e41621

Informations de copyright

Copyright © 2023, Judd et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Med. 2019 Nov 5;16(11):e1002922
pubmed: 31689290
MMWR Morb Mortal Wkly Rep. 2016 Jan 01;64(50-51):1378-82
pubmed: 26720857
Mo Med. 2017 Mar-Apr;114(2):82-90
pubmed: 30228543
Ann Surg. 2020 Dec;272(6):879-886
pubmed: 32657939
Ann Epidemiol. 2018 Sep;28(9):641-652
pubmed: 29921551
Addict Behav. 2009 Mar;34(3):258-63
pubmed: 19008050
J Health Econ. 2021 Jan;75:102408
pubmed: 33316762
Clin Orthop Relat Res. 2020 Feb;478(2):205-215
pubmed: 31389888
Acta Anaesthesiol Scand. 2014 Apr;58(4):437-45
pubmed: 24593770
J Rural Health. 2023 Feb 12;:
pubmed: 36775905
Anesth Analg. 2017 Nov;125(5):1741-1748
pubmed: 29049118
Ophthalmology. 2020 Nov;127(11):1454-1459
pubmed: 32654758
Drug Alcohol Depend. 2021 May 1;222:108668
pubmed: 33766441
Addiction. 2017 Oct;112(10):1784-1796
pubmed: 28498498
J Law Med Ethics. 2018 Jun;46(2):387-403
pubmed: 30146997
JAMA. 2015 Mar 3;313(9):891-2
pubmed: 25622279
BMJ. 2017 Oct 19;359:j4792
pubmed: 29051174
JAMA Netw Open. 2018 Jun 1;1(2):e180217
pubmed: 30646062
Ann Surg. 2018 Mar;267(3):468-472
pubmed: 28267689
Drug Alcohol Rev. 2019 Jul;38(5):494-502
pubmed: 31317593
Ann Surg. 2017 Oct;266(4):564-573
pubmed: 28697049
Subst Abus. 2020;41(1):35-69
pubmed: 31403903
BMJ Open. 2022 May 2;12(5):e053686
pubmed: 35501103
Int J Drug Policy. 2018 Jul;57:119-129
pubmed: 29754032
PLoS One. 2020 Jan 17;15(1):e0227966
pubmed: 31951640
Prev Med. 2021 Nov;152(Pt 2):106541
pubmed: 34482994
Am J Drug Alcohol Abuse. 2023 Mar 4;49(2):260-265
pubmed: 36961998
JAMA Netw Open. 2018 Sep 7;1(5):e182908
pubmed: 30646184
Am J Public Health. 2017 Oct;107(10):1564-1565
pubmed: 28902554
BMC Health Serv Res. 2019 Nov 1;19(1):784
pubmed: 31675963
Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):618-27
pubmed: 16862602
Jt Comm J Qual Patient Saf. 2021 Jul;47(7):431-437
pubmed: 33896745
J Addict Med. 2017 Jul/Aug;11(4):315-319
pubmed: 28426439
Mayo Clin Proc. 2020 May;95(5):968-981
pubmed: 32171474
BJU Int. 2018 Nov;122(5):754-759
pubmed: 29896932

Auteurs

Dallin Judd (D)

Medicine, Texas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, USA.

Connor R King (CR)

Marriott School of Business, Brigham Young University, Provo, USA.

Curtis Galke (C)

Family Medicine and OMM, Texas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, USA.

Classifications MeSH